Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

EQT to sell E.I.S. Aircraft Group’s aviation operations business to QinetiQ

· EQT Mid Market sells airborne training services business E.I.S. Aircraft Operations, part of E.I.S. Aircraft Group, to QinetiQ · EQT Mid Market remains invested in E.I.S. Aircraft Group’s light-weight aviation cabin interior products and maintenance services business E.I.S. Aircraft Products & Services · The transaction has a strong industrial fit and will benefit both parties’ international growth strategies, both in terms of regional and global reach and the ability to deliver additional customer services Supported by EQT Mid Market since 2015, E.I.S. Aircraft Operations,

Interim report January-March 2018

Gothenburg, Sweden – Collector AB (publ) (Nasdaq Stockholm: COLL)JANUARY–MARCH 2018 (COMPARED WITH JANUARY–MARCH 2017) ·  Income increased by 17 percent, amounting to SEK 511 million (438) ·  Earnings after tax (EAT) were SEK 112 million (113) ·  Higher expenses than historical relating to adaptations to regulations, double license and operating expenses, moving expenses and investments in new digital offerings. ·  Return on equity (RoE) was 18 percent (20) ·  Earnings per share, 1.09 (1.11) ·  Good volume growth in the credit portfolio, SEK 20,232 million (14,973), 35

​Telenor Sweden AB: Flowscape's second largest order ever

Through its partner Atea, Flowscape has signed a three-year agreement with Telenor Sweden AB. The value of the order is a total of 7,5 MSEK. With the help of Flowscape's system, Telenor will be able to develop its way of working, thus contributing in creating a modern workplace. The order, that came to life through the partner Atea, consists of both hardware and software and includes over 40 room panels, over 1 000 sensors and a support agreement. The order has a value of 7,5 MSEK with a duration of 3 years. It makes the deal Flowscapes second largest ever. "Telenor's fundamental

Invitation to Nixu’s Capital Markets Day on May 31, 2018

Nixu CorporationPress release, April 24, 2018 at 9.05 am EESTEuropean cybersecurity company Nixu is pleased to invite investors, analysts and media to its Capital Markets Day, to be held on Thursday, May 31, 2018. The purpose of the Capital Markets Day is to provide information on the progress of Nixu’s growth strategy, future strategic priorities, current cyber-threat landscape and the overall development of the cybersecurity market. The event will be held in English at the Nixu headquarters in Finland (address: Keilaranta 15, 02150 Espoo). The event registration opens and coffee is

Gunnebo Interim Report January-March 2018

Comments on the first quarter by Gunnebo’s President and CEO, Henrik LangeSales during the first quarter of the year were slightly lower than the corresponding quarter of 2017 when several major projects were delivered. This, as well as continued challenges with profitability in France, have led to a lower operating profit of MSEK 49. Cash flow for the quarter was MSEK 39, which is a clear improvement compared to the first quarter of last year. DEVELOPMENT OF OUR BUSINESS The strategic review of our French business continued during the first quarter. Our main focus is to reposition

Alimak Group AB publishes Annual Report 2017

Alimak Group AB’s Annual Report 2017 including the sustainability report has been published on www.alimakgroup.com in English and Swedish.The Annual Report will also been printed in a limited edition and can be ordered from investor@alimakgroup.com. Stockholm, 24 April 2018 Alimak Group AB For further information, contact: Mathilda Eriksson, IR Manager, +46 8 402 14 41 This information is information that Alimak Group AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 08.00 CET on 24 April 2018. About

Bambuser Announces New Go-to-Market Strategy

During the past six weeks, Bambuser’s new management team has implemented further cost reductions and presented a new, more focused, go-to-market strategy, which has been approved by the Board of Directors.Starting after a challenging period with less sales than expected, the new management team headed by interim CEO Maryam Ghahremani has put forward a number of strategic changes for Bambuser. In addition to the staff cuts announced in February 2018, an additional four employees have been given notice in order to reduce costs. The Company’s resources will focus on generating revenue through

Betsson AB publishes Annual Report for 2017

Betsson's Annual Report for 2017 is now available on the company's website, www.betssonab.com. For further information, please contact:Pia Rosin, VP Corporate Communication Betsson AB+46 (0)73 600 85 00, pia.rosin@betssonab.com This information is information that Betsson AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, on April 24th, 2018, at 08.00 CET.

Collector signs agreement with Apoteket

Collector Bank and Apoteket have signed an agreement for payment solutions, commencing in 2019.The agreement encompasses Swedish pharmacy chain Apoteket’s entire invoice flow to consumers in the sales channels e-commerce and retail through 394 stores, as well as other remote trading. Apoteket is Sweden’s largest pharmacy chain and has annual sales of slightly more than SEK 20 billion. “During the procurement process, Collector has been strongly committed to designing a comprehensive solution that meets Apoteket’s efforts to create simplicity in all channels, both for our customers and

Interim report Q1 of Cloetta AB January – March 2018

Good EBIT delivery and Easter sales• Net sales for the quarter increased by 27.8 per cent to SEK 1,562m (1,222), of which acquisition growth amounted to 24.5 per cent and exchange rate differences to 2.2 per cent. Organic growth amounted to 1.1 per cent. • Operating profit, adjusted amounted to SEK 164m (114). • Operating profit amounted to SEK 166m (97). Profit for the period amounted to SEK 95m (59). • Cash flow from operating activities amounted to SEK –29m (155). • Net debt/EBITDA ratio was 2.42 (2.34). Please find enclosed the full report. The interim report will be

AstraZeneca:high level results of the ARCTIC trial

24 April 2018 07:00 BST ASTRAZENECA REPORTS RESULTS FROM THE ARCTIC TRIAL IN THIRD-LINE NON-SMALL CELL LUNG CANCER AstraZeneca and MedImmune, its global biologics research and development arm, today announced high-level results from the Phase III ARCTIC trial in patients with locally-advanced or metastatic non-small cell lung cancer (NSCLC) who have received at least two prior treatments. This randomised, open-label, multi-centre trial assessed the efficacy and safety of the combination of Imfinzi (durvalumab) plus tremelimumab, as well as Imfinzi and tremelimumab monotherapies,

Invitation to presentation of Recipharm’s interim report for the first quarter 2018 on the 27th April

Recipharm will publish its interim report for January-March 2018 on 27 April at 07:45 am CET. The company invites investors, analysts and media to a web conference (in English) on 27 April at 10:00 am CET, where CEO Thomas Eldered and CFO Henrik Stenqvist will present and comment on the report as well as answer questions. The report will be available on Recipharm’s website www.recipharm.com/investor-relations from 7:45 am CET the same day and the presentation from the webcast will be uploaded during the day on the 27th April. To participate in the web conference, please use the

Interim-report Jan-Mar 2018

Increased rental income and record high return on projects · Rental income increased to SEK 614m (546). In an identical portfolio, income rose by approximately13 per cent. · Net operating income increased to SEK 439m ((379). In an identical portfolio, net operating income rose by approximately 17 per cent. · The surplus ratio was 72 per cent (69). · Profit from property management increased with 27 per cent to SEK 274m (216). · Realised and unrealised changes in value amounted to SEK 2,783m (833) · Net lettings during the period totalled SEK 9m (21). · After-tax

Interim report January-March 2018: Strong development continues

· Result for the quarter is GHP’s best first quarter so far · Organic growth of over 10 percent · Rolling 12-month sales revenues exceed SEK 1 billion for the first time · Work on the action programme continues · Decision to expand Gildhöj in Copenhagen  First quarter 2018 · Sales revenues increased to SEK 278.7 million (260.8) · Organic growth amounted to 10.7 percent (11.0) · EBITDA amounted to SEK 25.8 million (18.2) · EBITDA margin amounted to 9.3 percent (7.0) · Result after tax (EAT) amounted to SEK 14.0 million (8.2) · Result per share amounted to

IK Small Cap II Fund to support Bahr Modultechnik GmbH

IK Investment Partners (“IK”), a leading Pan-European private equity firm, is pleased to announce that the IK Small Cap II Fund together with Management and the founders has reached an agreement to acquire Bahr Modultechnik GmbH (“Bahr” or “the Company”), a leading manufacturer of modular positioning systems. Financial terms of the transaction are not disclosed, and the completion of the transaction is subject to regulatory approvals.Founded in 1990 by the brothers Frank and Dirk Bahr, Bahr Modultechnik focuses on delivering individual solutions based on a sophisticated portfolio of

Concentric AB appoints Philip Broad as Vice President of Sales for Enginesin Europe and Asia

Philip Broad is appointed Vice President of Sales in Europe and Asia for Engine Products. Philip holds a B.Eng (Hons) in Systems Engineering and has over 20 years of experience in the commercial vehicle marketplace both on and off highway, in business development, programme management and sales leadership. He has lived and worked from a Central European base for the last 15 years for Honeywell Turbo Technologies in Switzerland where he held the position of Global Business Manager for Turbochargers. Philip has a proven track record of winning large, profitable contracts in the commercial

Interim report January – March 2018

Kai Wärn, President and CEO:“Cold weather delayed the start of the gardening season in Europe as well as in North America, resulting in low sell-through at our trade partners. Despite the weather issues, the three divisions in profitable growth mode continued their growth trajectory with higher operating income and margin at the same time as continuing to invest in growth initiatives. The Group operating income of SEK 1,373m (1,425) was slightly below last year as the Consumer Brands Division had a challenging start to the year. However, the operating margin for the Group remained on a

Polygiene establishes a new group management team to accelerate growth, profitability and organizational development

As a result of a 100-day analysis conducted by CEO Ulrika Björk since her appointment as new CEO of Polygiene AB, a new group management team will be put into place effective today. The aim is to accelerate growth, cost control, profitability and organizational development.Haymo Strubel, Director of Sales for Europe, has been appointed as Chief Sales Officer. The position and duties of Vice President, New Ventures and Strategies, will become the responsibility of Chief Commercial Officer, held by Peter Sjösten. Finally, Paul Middleton has been appointed as Chief Technology Officer.

InDex Pharmaceuticals Holding AB (publ) publishes Annual Report for 2017

April 24, 2018 – InDex Pharmaceuticals Holding AB (publ) today publishes the Annual Report for 2017. The Annual Report (in the Swedish language) is attached as a PDF and is available on the company’s website, www.indexpharma.com.The printed Annual Report is mailed to shareholders and other stakeholders who specifically request it. Send request to info@indexpharma.com, or by mail to InDex Pharmaceuticals Holding AB (publ), Tomtebodavägen 23a, 171 77 Stockholm. For more information:Peter Zerhouni, CEOPhone: +46 8 508 847 35E-mail: peter.zerhouni@indexpharma.com InDex

ROTTNEROS INTERIM REPORT JANUARY – MARCH 2018

STRONG PROFIT GROWTH · Net turnover in the first quarter of 2018 rose by 15% to SEK 541m (472). · The profit after financial items for the first quarter increased by 30% to 73m (56). Earnings per share for the quarter were SEK 0.37 (0.28). · NBSK list price during the first quarter of 2018 was 18% higher in SEK compared with the first quarter of 2017. Compared with the fourth quarter of 2017, the list price in SEK was 8% higher. · Rising pulp wood prices have a negative impact on results. · Production volume for the quarter was 99.9 (102.9) thousand tonnes. A new quarterly

Nordic forest companies lack a clear digitalization strategy

More than half of Swedish and Finnish forest companies lack a concrete digitalization strategy. At the same time both countries have a positive approach to digital business opportunities and consider the use of real-time data, user experience, and business transformation as areas of great potential. These are some of the key findings in Tieto’s report: Forest Industry’s IT Barometer 2018.In Sweden and Finland, an increasing number of forest companies have a business strategy for digitalization, but the majority still lack one (57% in Sweden and 51% in Finland). A similar pattern can be seen

New forecast: Global boom starting to cool

In Handelsbanken's second macro forecast for the year, we note that the Swedish economy is strong at the moment, but we expect growth to taper off ahead. Housing construction will soon slow and external support will eventually diminish. The economic upturn has contributed to exceptional jobs growth and gradually rising inflation. As a consequence, we expect the Riksbank to initiate rate hikes in December. The Swedish krona will gradually strengthen from today’s weak level.· Swedish economy in full swing, but construction will soon slow · The Riksbank will raise the policy rate in

Wallenstam Interim report January 1–March 31, 2018: Stable and value-creating operations

CEO Hans Wallenstam and Regional Director Gothenburg business area Marina Fritsche comment on the report at www.wallenstam.se/filmsandpresentations. The film will be released by 08.30 (CET) at the latest. A conference call with Susann Linde, CFO and Head of Investor Relations, will take place at 10.00 (CET) at www.financialhearings.com. The presentation is available at www.wallenstam.se/filmsandpresentations. JANUARY 1–MARCH 31, 2018 · The growth rate in net asset value, excluding dividends and repurchases, amounted to 11.9 percent. · Income from property management increased

Availability of orphan medicines varies between European countries

There are differences in the availability of orphan medicines between different European countries, a new study from the University of Eastern Finland shows. Orphan medicines are pharmaceutical products developed specifically for the treatment, prevention or diagnostics of rare diseases. Rare diseases are life-threatening or permanently disabling medical conditions, and they affect some 30 million people in Europe and more than 300,000 people in Finland alone. People suffering from a rare disease do not always have access to the medicines they need. Factors limiting the availability of

There are no items matching the current filter
There are no more items matching the current filter
Back to top